Who are we?
The team works toward improving global health by developing new therapeutic solutions with greater worldwide access. With their network of partners, they are developing the next generation of best-in-class medicine.
Breaking the barrier for LAI adoption:
BEPO®, their long-acting injectable (LAI), meets health challenges on a global scale. By addressing issues of compliance, development timelines, tolerance, and costs, BEPO® provides opportunities for their partners to collaborate with them to achieve better outcomes for patients worldwide.